Kyverna Therapeutics (KYTX) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.13
-1.02
-0.91
-0.8

Details

Expected EPS
-1.043887
Actual EPS
-0.97
Surprise EPS
0.07
Surprise Percent
+7.08%

Description

Kyverna Therapeutics (KYTX) has reported earnings of -0.97 per share for Q3 2025.

0 Comments

Share your thoughts